Impact of antithrombotic agents on the clinical course after pancreatectomy

Impact of antithrombotic agents on the clinical course after pancreatectomy - Impact of antithrombotic agents on the clinical course after pancreatectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037621

Enrollment

12000

Registered

2019-08-07

Start date

2019-08-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer, Bile duct cancer, Periampullary carcinoma, IPMN, Others

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent pancreatectomy at 94 high-volume centers participating in the project study of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. between January 2015 and December 2017.

Exclusion criteria

Exclusion criteria: Patients under 20 years old. Patients who do not agree by consent forms to attend this study.

Design outcomes

Primary

Measure	Time frame
Incidence of postpancreatectomy hemorrhage	—

Countries

Japan

Contacts

Public ContactKota Nakamura

Nara Medical University Department of Surgery

knaka@naramed-u.ac.jp0744-22-3051

Outcome results